Study of HER2/neu status in Qatari women with breast carcinoma

Kakil I. Rasul; Kelta Mohammaed; Awidi S. Abdalla; Augustin Chong-Lopez; Mubarak A. Ahmad; Mohammed U. Al-Homsi; Asma M. Al-Hassan; Ahmad S. Al-Alosi; Bener A. Bener

Article Information

vol. 24 no. 8 832-836

PubMed

12939666

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Published online January 8, 2021.

Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

Kakil I. Rasul,
Kelta Mohammaed,
Awidi S. Abdalla,
Augustin Chong-Lopez,
Mubarak A. Ahmad,
Mohammed U. Al-Homsi,
Asma M. Al-Hassan,
Ahmad S. Al-Alosi and
Bener A. Bener

Consultant Hematologist/Oncologist, Hamad Medical Corporation, Department of Medicine, PO Box 3050, Doha, Qatar. Tel. +974 4884512. Fax. +974 4392273. E-mail: kakil{at}hmc.org.qa
Department of Medicine Hematology/Oncology Section, Hamad Medical Corporation, Doha, Qatar.
Department of Medicine Hematology/Oncology Section, Hamad Medical Corporation, Doha, Qatar.
Department of Pathology, Hamad Medical Corporation, Doha, Qatar.
Department of Medicine Hematology/Oncology Section, Hamad Medical Corporation, Doha, Qatar.
Department of Medicine Hematology/Oncology Section, Hamad Medical Corporation, Doha, Qatar.
Department of Medicine Hematology/Oncology Section, Hamad Medical Corporation, Doha, Qatar.
Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, Doha, Qatar.
Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, Doha, Qatar.